Drugs for Vaginal Fungal Infections - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2758031
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 156
-
According to Ample Market Research, the global market for Drugs for Vaginal Fungal Infections should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Drugs for Vaginal Fungal Infections market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Drugs for Vaginal Fungal Infections market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
This report studies and analyses global Drugs for Vaginal Fungal Infections status and future trends, to help determine the Drugs for Vaginal Fungal Infections market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Drugs for Vaginal Fungal Infections, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Drugs for Vaginal Fungal Infections market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Drugs for Vaginal Fungal Infections by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Drugs for Vaginal Fungal Infections by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Drugs for Vaginal Fungal Infections key consuming regions, consumption value and demand structure
(5) Drugs for Vaginal Fungal Infections industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Pfizer Inc.
Bausch Health Companies Inc
ANl Pharmaceuticals, Inc
Hikma Pharmaceuticals Plc
Lupin Limited
Mycovia Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC Medical AB
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
SCYNEXIS,Inc.
Basilea Pharmaceutica Ltd.
Astellas Pharma lnc.
Grupo Ferrer Internacional,S.A.
Pacgen Life Science Corporation
NovaDigm Therapeutics, Inc.
Cidara Therapeutics, Inc.
Amplyx Pharmaceuticals Inc.
Market segment by Type, covers
Fluconazole
Nystatin
Flucytosine
Clotrimazole
Others
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Drugs for Vaginal Fungal Infections product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Drugs for Vaginal Fungal Infections market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Drugs for Vaginal Fungal Infections market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Drugs for Vaginal Fungal Infections industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Drugs for Vaginal Fungal Infections Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Drugs for Vaginal Fungal Infections Definition
1.2 Global Drugs for Vaginal Fungal Infections Market Size and Forecast
1.3 China Drugs for Vaginal Fungal Infections Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Drugs for Vaginal Fungal Infections Market Size: China VS Global Growth Rate, 2018-2029
1.6 Drugs for Vaginal Fungal Infections Market Dynamics
1.6.1 Drugs for Vaginal Fungal Infections Market Drivers
1.6.2 Drugs for Vaginal Fungal Infections Market Restraints
1.6.3 Drugs for Vaginal Fungal Infections Industry Trends
1.6.4 Drugs for Vaginal Fungal Infections Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Drugs for Vaginal Fungal Infections, Global Market Share by Company, 2018-2023
2.2 Global Drugs for Vaginal Fungal Infections Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Drugs for Vaginal Fungal Infections Concentration Ratio
2.4 Global Drugs for Vaginal Fungal Infections Mergers & Acquisitions, Expansion Plans
2.5 Global Drugs for Vaginal Fungal Infections Major Companies Product Type
2.6 Head Office and Drugs for Vaginal Fungal Infections Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Drugs for Vaginal Fungal Infections, China Market Share by Company, 2018-2023
3.2 China Drugs for Vaginal Fungal Infections Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Drugs for Vaginal Fungal Infections Industry Chain
4.2 Drugs for Vaginal Fungal Infections Upstream Analysis
4.2.1 Drugs for Vaginal Fungal Infections Core Raw Materials
4.2.2 Main Manufacturers of Drugs for Vaginal Fungal Infections Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Drugs for Vaginal Fungal Infections Production Mode
4.6 Drugs for Vaginal Fungal Infections Procurement Model
4.7 Drugs for Vaginal Fungal Infections Industry Sales Model and Sales Channels
4.7.1 Drugs for Vaginal Fungal Infections Sales Model
4.7.2 Drugs for Vaginal Fungal Infections Typical Distributors
5 Sights by Type5.1 Drugs for Vaginal Fungal Infections Classification
5.1.1 Fluconazole
5.1.2 Nystatin
5.1.3 Flucytosine
5.1.4 Clotrimazole
5.1.5 Others5.2 By Type, Global Drugs for Vaginal Fungal Infections Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Drugs for Vaginal Fungal Infections Consumption Value, 2018-2029
6 Sights by Application6.1 Drugs for Vaginal Fungal Infections Segment by Application
6.1.1 Hospital
6.1.2 Clinic
6.1.3 Others6.2 By Application, Global Drugs for Vaginal Fungal Infections Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Drugs for Vaginal Fungal Infections Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Drugs for Vaginal Fungal Infections Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Drugs for Vaginal Fungal Infections Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Drugs for Vaginal Fungal Infections & Forecasts, 2018-2029
7.3.2 By Country, North America Drugs for Vaginal Fungal Infections Market Size Market Share7.4 Europe
7.4.1 Europe Drugs for Vaginal Fungal Infections Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Drugs for Vaginal Fungal Infections Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Drugs for Vaginal Fungal Infections Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Drugs for Vaginal Fungal Infections Market Size Market Share7.6 South America
7.6.1 South America Drugs for Vaginal Fungal Infections Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Drugs for Vaginal Fungal Infections Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Drugs for Vaginal Fungal Infections Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Drugs for Vaginal Fungal Infections Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Drugs for Vaginal Fungal Infections Market Size, 2018-2029
8.3.2 By Type, U.S. Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Drugs for Vaginal Fungal Infections Market Size, 2018-2029
8.4.2 By Type, Europe Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Drugs for Vaginal Fungal Infections Market Size, 2018-2029
8.5.2 By Type, China Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Drugs for Vaginal Fungal Infections Market Size, 2018-2029
8.6.2 By Type, Japan Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Drugs for Vaginal Fungal Infections Market Size, 2018-2029
8.7.2 By Type, South Korea Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Drugs for Vaginal Fungal Infections Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Drugs for Vaginal Fungal Infections Market Size, 2018-2029
8.9.2 By Type, India Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Drugs for Vaginal Fungal Infections Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Drugs for Vaginal Fungal Infections Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Company Information, Head Office, Market Area and Industry Position
9.1.2 Pfizer Inc. Company Profile and Main Business
9.1.3 Pfizer Inc. Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.1.4 Pfizer Inc. Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.1.5 Pfizer Inc. Recent Developments9.2 Bausch Health Companies Inc
9.2.1 Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position
9.2.2 Bausch Health Companies Inc Company Profile and Main Business
9.2.3 Bausch Health Companies Inc Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.2.4 Bausch Health Companies Inc Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.2.5 Bausch Health Companies Inc Recent Developments9.3 ANl Pharmaceuticals, Inc
9.3.1 ANl Pharmaceuticals, Inc Company Information, Head Office, Market Area and Industry Position
9.3.2 ANl Pharmaceuticals, Inc Company Profile and Main Business
9.3.3 ANl Pharmaceuticals, Inc Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.3.4 ANl Pharmaceuticals, Inc Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.3.5 ANl Pharmaceuticals, Inc Recent Developments9.4 Hikma Pharmaceuticals Plc
9.4.1 Hikma Pharmaceuticals Plc Company Information, Head Office, Market Area and Industry Position
9.4.2 Hikma Pharmaceuticals Plc Company Profile and Main Business
9.4.3 Hikma Pharmaceuticals Plc Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.4.4 Hikma Pharmaceuticals Plc Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.4.5 Hikma Pharmaceuticals Plc Recent Developments9.5 Lupin Limited
9.5.1 Lupin Limited Company Information, Head Office, Market Area and Industry Position
9.5.2 Lupin Limited Company Profile and Main Business
9.5.3 Lupin Limited Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.5.4 Lupin Limited Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.5.5 Lupin Limited Recent Developments9.6 Mycovia Pharmaceuticals, Inc.
9.6.1 Mycovia Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position
9.6.2 Mycovia Pharmaceuticals, Inc. Company Profile and Main Business
9.6.3 Mycovia Pharmaceuticals, Inc. Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.6.4 Mycovia Pharmaceuticals, Inc. Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.6.5 Mycovia Pharmaceuticals, Inc. Recent Developments
9.7 Glenmark Pharmaceuticals Limited
9.7.1 Glenmark Pharmaceuticals Limited Company Information, Head Office, Market Area and Industry Position
9.7.2 Glenmark Pharmaceuticals Limited Company Profile and Main Business
9.7.3 Glenmark Pharmaceuticals Limited Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.7.4 Glenmark Pharmaceuticals Limited Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.7.5 Glenmark Pharmaceuticals Limited Recent Developments
9.8 Unique Pharmaceuticals
9.8.1 Unique Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.8.2 Unique Pharmaceuticals Company Profile and Main Business
9.8.3 Unique Pharmaceuticals Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.8.4 Unique Pharmaceuticals Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.8.5 Unique Pharmaceuticals Recent Developments
9.9 PEPTONIC Medical AB
9.9.1 PEPTONIC Medical AB Company Information, Head Office, Market Area and Industry Position
9.9.2 PEPTONIC Medical AB Company Profile and Main Business
9.9.3 PEPTONIC Medical AB Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.9.4 PEPTONIC Medical AB Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.9.5 PEPTONIC Medical AB Recent Developments9.10 Aurobindo Pharma Limited
9.10.1 Aurobindo Pharma Limited Company Information, Head Office, Market Area and Industry Position
9.10.2 Aurobindo Pharma Limited Company Profile and Main Business
9.10.3 Aurobindo Pharma Limited Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.10.4 Aurobindo Pharma Limited Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.10.5 Aurobindo Pharma Limited Recent Developments
9.11 Dr. Reddy's Laboratories
9.11.1 Dr. Reddy's Laboratories Company Information, Head Office, Market Area and Industry Position
9.11.2 Dr. Reddy's Laboratories Company Profile and Main Business
9.11.3 Dr. Reddy's Laboratories Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.11.4 Dr. Reddy's Laboratories Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.11.5 Dr. Reddy's Laboratories Recent Developments
9.12 SCYNEXIS,Inc.
9.12.1 SCYNEXIS,Inc. Company Information, Head Office, Market Area and Industry Position
9.12.2 SCYNEXIS,Inc. Company Profile and Main Business
9.12.3 SCYNEXIS,Inc. Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.12.4 SCYNEXIS,Inc. Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.12.5 SCYNEXIS,Inc. Recent Developments
9.13 Basilea Pharmaceutica Ltd.
9.13.1 Basilea Pharmaceutica Ltd. Company Information, Head Office, Market Area and Industry Position
9.13.2 Basilea Pharmaceutica Ltd. Company Profile and Main Business
9.13.3 Basilea Pharmaceutica Ltd. Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.13.4 Basilea Pharmaceutica Ltd. Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.13.5 Basilea Pharmaceutica Ltd. Recent Developments
9.14 Astellas Pharma lnc.
9.14.1 Astellas Pharma lnc. Company Information, Head Office, Market Area and Industry Position
9.14.2 Astellas Pharma lnc. Company Profile and Main Business
9.14.3 Astellas Pharma lnc. Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.14.4 Astellas Pharma lnc. Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.14.5 Astellas Pharma lnc. Recent Developments
9.15 Grupo Ferrer Internacional,S.A.
9.15.1 Grupo Ferrer Internacional,S.A. Company Information, Head Office, Market Area and Industry Position
9.15.2 Grupo Ferrer Internacional,S.A. Company Profile and Main Business
9.15.3 Grupo Ferrer Internacional,S.A. Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.15.4 Grupo Ferrer Internacional,S.A. Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.15.5 Grupo Ferrer Internacional,S.A. Recent Developments
9.16 Pacgen Life Science Corporation
9.16.1 Pacgen Life Science Corporation Company Information, Head Office, Market Area and Industry Position
9.16.2 Pacgen Life Science Corporation Company Profile and Main Business
9.16.3 Pacgen Life Science Corporation Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.16.4 Pacgen Life Science Corporation Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.16.5 Pacgen Life Science Corporation Recent Developments
9.17 NovaDigm Therapeutics, Inc.
9.17.1 NovaDigm Therapeutics, Inc. Company Information, Head Office, Market Area and Industry Position
9.17.2 NovaDigm Therapeutics, Inc. Company Profile and Main Business
9.17.3 NovaDigm Therapeutics, Inc. Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.17.4 NovaDigm Therapeutics, Inc. Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.17.5 NovaDigm Therapeutics, Inc. Recent Developments
9.18 Cidara Therapeutics, Inc.
9.18.1 Cidara Therapeutics, Inc. Company Information, Head Office, Market Area and Industry Position
9.18.2 Cidara Therapeutics, Inc. Company Profile and Main Business
9.18.3 Cidara Therapeutics, Inc. Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.18.4 Cidara Therapeutics, Inc. Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.18.5 Cidara Therapeutics, Inc. Recent Developments
9.19 Amplyx Pharmaceuticals Inc.
9.19.1 Amplyx Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position
9.19.2 Amplyx Pharmaceuticals Inc. Company Profile and Main Business
9.19.3 Amplyx Pharmaceuticals Inc. Drugs for Vaginal Fungal Infections Models, Specifications and Application
9.19.4 Amplyx Pharmaceuticals Inc. Drugs for Vaginal Fungal Infections Revenue and Gross Margin, 2018-2023
9.19.5 Amplyx Pharmaceuticals Inc. Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Drugs for Vaginal Fungal Infections Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Drugs for Vaginal Fungal Infections Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Depending upon the type of applications, the Drugs for Vaginal Fungal Infections Global and China Top Players Market has been segmented into
In 2023, the Drugs for Vaginal Fungal Infections Global and China Top Players Market share surpassed USD xx million, and between 2024 and 2029, it will grow at a CAGR of yy%.
As the shift to value addition continues, companies in the Drugs for Vaginal Fungal Infections Global and China Top Players Market face the dual challenge of improving interoperability to optimize performance and experience.
The Drugs for Vaginal Fungal Infections Global and China Top Players analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.
